Watch the recording of this session in the AD/PD™ Education portal!
This session brought together esteemed experts Stephen Gomperts, MD, PhD, Nikolaus McFarland, MD, PhD and Anne-Marie Wills, MD, MPH. The session was moderated by Prof. Werner Poewe.
- Stephen N. Gomperts, MD, PhD, Associate Professor of Neurology, Harvard Medical School, board-certified neurologist, dementia and movement disorders specialist, and Director of the Lewy Body Dementia Unit at Massachusetts General Hospital
- Nikolaus McFarland, MD, PhD, associate professor of neurology at the University of Florida Department of Neurology, board-certified neurologist and movement disorders specialist at the Norman Fixel Institute for Neurological Diseases at UF Health
- Werner Poewe, MD, PhD, Professor of Neurology and Director of the Department of Neurology at Innsbruck Medical University in Innsbruck, Austria
- Anne-Marie Wills, MD, MPH, board-certified neurologist at Massachusetts General Hospital and Director of the Mass General Progressive Supranuclear Palsy (PSP) Clinic
Through this session you will learn how to:
- Define the clinical criteria for diagnosing atypical Parkinsonism, specifically DLB, PSP, and MSA.
- Understand the biomarker criteria unique to each neurodegenerative disorder, enabling them to differentiate these from markers used in the diagnosis of Idiopathic PD.
|Welcome & Introductions||Werner Poewe||5 min|
|Dementia with Lewy Bodies (DLB)||Stephen Gomperts||15 min|
|Progressive Supranuclear Palsy (PSP)||Anne-Marie Wills||15 min|
|Multiple system atrophy (MSA)||Nikolaus McFarland||15 min|
|Q&A + Panel discussion||All speakers||20 min|
|Closing remarks||Werner Poewe||5 min|
NOTE! Please make sure you Log In or Register before you click this link.